HB Wealth Management’s Bio-Techne TECH Stock Holding History

HB Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$674K	Sell	9,545 -24,595	-72%	-$1.33M	﹤0.01%	954
2026 Q1	$1.78M	Sell	34,140 -5,709	-14%	-$343K	0.01%	464
2025 Q4	$2.34M	Sell	39,849 -89	-0.2%	-$5.41K	0.02%	381
2025 Q3	$2.22M	Sell	39,938 -15,466	-28%	-$828K	0.02%	392
2025 Q2	$2.85M	Buy	55,404 +669	+1%	+$33.6K	0.02%	308
2025 Q1	$3.21M	Buy	+54,735	New	+$3.71M	0.03%	295
2022 Q1	–	Sell	-1,608	Closed	-$208K	–	619
2021 Q4	$208K	Buy	+1,608	New	+$197K	﹤0.01%	486

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HB Wealth Management's TECH Position: Q2 2026 in Review

HB Wealth Management reduced its Bio-Techne (TECH) stake by 72% in Q2 2026, selling an estimated $1.33M and leaving 9,545 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #954.

HB Wealth Management first reported a position in TECH in Q4 2021 and has held it in 7 quarters since. The position peaked at $3.21M in Q1 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

HB Wealth Management held 9,545 shares of Bio-Techne worth $674K as of Q2 2026.
HB Wealth Management sold 24,595 Bio-Techne shares in Q2 2026, an estimated $1.33M.
Bio-Techne made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #954 holding.
HB Wealth Management first reported a position in Bio-Techne in Q4 2021 and has held it in 7 quarters since.
HB Wealth Management's Bio-Techne position peaked at $3.21M in Q1 2025.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.